Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Preferred Stock Liabilities (2024 - 2025)

Carlsmed filings provide 2 years of Preferred Stock Liabilities readings, the most recent being $65.4 million for Q2 2025.

  • On a quarterly basis, Preferred Stock Liabilities rose 381.29% to $65.4 million in Q2 2025 year-over-year; TTM through Jun 2025 was $65.4 million, a 381.29% increase, with the full-year FY2024 number at $29.8 million, changed N/A from a year prior.
  • Preferred Stock Liabilities hit $65.4 million in Q2 2025 for Carlsmed, up from $29.8 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $65.4 million in Q2 2025 to a low of $13.6 million in Q2 2024.